LAG3 and neoplasm: LAG3Ab not only blocked the binding of LAG3 expressed in DNT cell surface to its ligands expressed in tumor cells, but also significantly enhanced the T‐BET transcription in DNT cells, which lays a reliable foundation for the application of ACT combined with ICIs in breast cancer, especially in TNBC.